David Lominadze

Dr. David Lominadze

USF, Department of Surgery, Morsani College of Medicine
+2
orcid

Research Focus & Metrics

Academic Career Length

45Years (1982-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 December 2009 in Acta Physiologica
Verified
Journal Article
Closed access
PDF file
David LominadzeDavid Lominadze
David Lominadze
WDW. L. Dean
W. L. Dean
STS. C. Tyagi
S. C. Tyagi
ARA. M. Roberts
A. M. Roberts

1 January 2012 in International Journal of Biological Sciences
Verified
Journal Article
Open access
NQNatia Qipshidze
Natia Qipshidze
NMNaira Metreveli
Naira Metreveli
PMParas K. Mishra
Paras K. Mishra
David LominadzeDavid Lominadze
David Lominadze
STSuresh C. Tyagi
Suresh C. Tyagi
Exogenous hydrogen sulfide (H2S) leads to down-regulation of inflammatory responses and provides myocardial protection during acute ischemia/reperfusion injury; however its role during chronic heart failure (CHF) due to myocardial infarction (MI) is yet to be unveiled. We previously reported that H2S inhibits antiangiogenic factors such, as endostatin and angiostatin, but a little is known about its effect on parstatin (a fragment of proteinase-activated receptor-1, PAR-1). We hypothesize that H2S inhibits parstatin formation and promotes VEGF activation, thus promoting angiogenesis and significantly limiting the extent of MI injury. To verify this hypothesis MI was created in 12 week-old male mice by ligation of left anterior descending artery (LAD). Sham surgery was performed except LAD ligation. After the surgery mice were treated with sodium hydrogen sulfide (30 μmol/l NaHS, a donor for H2S, in drinking water) for 4 weeks. The LV tissue was analyzed for VEGF, flk-1 and flt-1, endostatin, angiostatin and parstatin. The expression of VEGF, flk-1 and flt-1 were significantly increased in treated mice while the level of endostatin, angiostatin and parstatin were decreased compared to in untreated mice. The echocardiography in mice treated with H2S showed the improvement of heart function compared to in untreated mice. The X-ray and Doppler blood flow measurements showed enhancement of cardiac-angiogenesis in mice treated with H2S. This observed cytoprotection was associated with an inhibition of anti-angiogenic proteins and stimulation of angiogenic factors. We established that administration of H2S at the time of MI ameliorated infarct size and preserved LV function during development of MI in mice. These results suggest that H2S is cytoprotective and angioprotective during evolution of MI.

1 January 2007 in Archives of Physiology and Biochemistry
Verified
Journal Article
Closed access
Alexander V OvechkinAlexander V Ovechkin
Alexander V Ovechkin
David LominadzeDavid Lominadze
David Lominadze
KSKara C. Sedoris
Kara C. Sedoris
TRTonya W. Robinson
Tonya W. Robinson
STSuresh C. Tyagi
Suresh C. Tyagi
ARAndrew M. Roberts
Andrew M. Roberts
Pulmonary ischemia–reperfusion (IR) injury may result from trauma, atherosclerosis, pulmonary embolism, pulmonary thrombosis and surgical procedures such as cardiopulmonary bypass and lung transplantation. IR injury induces oxidative stress characterized by formation of reactive oxygen (ROS) and reactive nitrogen species (RNS). Nitric oxide (NO) overproduction via inducible nitric oxide synthase (iNOS) is an important component in the pathogenesis of IR. Reaction of NO with ROS forms RNS as secondary reactive products, which cause platelet activation and upregulation of adhesion molecules. This mechanism of injury is particularly important during pulmonary IR with increased iNOS activity in the presence of oxidative stress. Platelet–endothelial interactions may play an important role in causing pulmonary arteriolar vasoconstriction and post-ischemic alveolar hypoperfusion. This review discusses the relationship between ROS, RNS, P-selectin, and platelet–arteriolar wall interactions and proposes a hypothesis for their role in microvascular responses during pulmonary IR.

1 March 2006 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Closed access
PDF file
David LominadzeDavid Lominadze
David Lominadze
ARAndrew M. Roberts
Andrew M. Roberts
NTNeetu Tyagi
Neetu Tyagi
KMKarni S. Moshal
Karni S. Moshal
STSuresh C. Tyagi
Suresh C. Tyagi
Elevated plasma homocysteine (Hcy) is associated with cerebrovascular disease and activates matrix metalloproteinases (MMPs), which lead to vascular remodeling that could disrupt the blood-brain barrier. To determine whether Hcy administration can increase brain microvascular leakage secondary to activation of MMPs, we examined pial venules by intravital video microscopy through a craniotomy in anesthetized mice. Bovine serum albumin labeled with fluorescein isothiocyanate (BSA-FITC) was injected into a carotid artery to measure extravenular leakage. Hcy (30 μM/total blood volume) was injected 10 min after FITC-BSA injection. Four groups of mice were examined: 1) wild type (WT) given vehicle; 2) WT given Hcy (WT + Hcy); 3) MMP-9 gene knockout given Hcy (MMP-9−/− + Hcy); and 4) MMP-9−/− with topical application of histamine (10−4 M) (MMP-9−/− + histamine). In the WT + Hcy mice, leakage of FITC-BSA from pial venules was significantly ( P < 0.05) greater than in the other groups. There was no significant leakage of pial microvessels in MMP-9−/− + Hcy mice. Increased cerebrovascular leakage in the MMP-9−/− + histamine group showed that microvascular permeability could still increase by a mechanism independent of MMP-9. Treatment of cultured mouse microvascular endothelial cells with 30 μM Hcy resulted in significantly greater F-actin formation than in control cells without Hcy. Treatment with a broad-range MMP inhibitor (GM-6001; 1 μM) ameliorated Hcy-induced F-actin formation. These data suggest that Hcy increases microvascular permeability, in part, through MMP-9 activation.

12 September 2007 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
NTNeetu Tyagi
Neetu Tyagi
ARAndrew M. Roberts
Andrew M. Roberts
WDWilliam L. Dean
William L. Dean
STSuresh C. Tyagi
Suresh C. Tyagi
David LominadzeDavid Lominadze
David Lominadze

22 March 2002 in FEBS Letters
Verified
Journal Article
Closed access
David LominadzeDavid Lominadze
David Lominadze
WDWilliam L Dean
William L Dean